File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.eurox.2025.100406
- Scopus: eid_2-s2.0-105007433518
- WOS: WOS:001510470000001
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: Focused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review
| Title | Focused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review |
|---|---|
| Authors | |
| Keywords | Cervix Focused ultrasound Human papillomavirus Squamous intraepithelial lesion |
| Issue Date | 28-May-2025 |
| Publisher | Elsevier B.V. |
| Citation | European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2025, v. 26 How to Cite? |
| Abstract | Focused ultrasound (FUS) appears to be a promising form of thermal ablation for treatment of cervical lesions, but evidence supporting its use is limited. This review evaluated the efficacy and safety of FUS treatment of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL). The overall efficacy of FUS on HPV clearance was 75.0–85.7 % at 3 months, 35.5–77.1 % at 6 months and 64.7–94.1 % at 12 months. Its efficacy on low grade SIL and high grade SIL regression were 83.3–96.8 % and 70.9–96.6 % at 6 months, respectively. Complications were uncommon. FUS appears to be an effective and safe treatment modality for cervical HPV and SIL. |
| Persistent Identifier | http://hdl.handle.net/10722/357955 |
| ISSN | 2023 Impact Factor: 1.5 2023 SCImago Journal Rankings: 0.527 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cheung, Vincent Y.T. | - |
| dc.date.accessioned | 2025-07-23T00:30:57Z | - |
| dc.date.available | 2025-07-23T00:30:57Z | - |
| dc.date.issued | 2025-05-28 | - |
| dc.identifier.citation | European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2025, v. 26 | - |
| dc.identifier.issn | 2590-1613 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/357955 | - |
| dc.description.abstract | Focused ultrasound (FUS) appears to be a promising form of thermal ablation for treatment of cervical lesions, but evidence supporting its use is limited. This review evaluated the efficacy and safety of FUS treatment of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL). The overall efficacy of FUS on HPV clearance was 75.0–85.7 % at 3 months, 35.5–77.1 % at 6 months and 64.7–94.1 % at 12 months. Its efficacy on low grade SIL and high grade SIL regression were 83.3–96.8 % and 70.9–96.6 % at 6 months, respectively. Complications were uncommon. FUS appears to be an effective and safe treatment modality for cervical HPV and SIL. | - |
| dc.language | eng | - |
| dc.publisher | Elsevier B.V. | - |
| dc.relation.ispartof | European Journal of Obstetrics & Gynecology and Reproductive Biology: X | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Cervix | - |
| dc.subject | Focused ultrasound | - |
| dc.subject | Human papillomavirus | - |
| dc.subject | Squamous intraepithelial lesion | - |
| dc.title | Focused ultrasound treatment of cervical human papillomavirus infection and squamous intraepithelial lesions: A narrative review | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1016/j.eurox.2025.100406 | - |
| dc.identifier.scopus | eid_2-s2.0-105007433518 | - |
| dc.identifier.volume | 26 | - |
| dc.identifier.isi | WOS:001510470000001 | - |
| dc.identifier.issnl | 2590-1613 | - |
